Oltmans Curtis Gale Insider Trading Activity

Average Profitability
68.04%
Insider Buys Quantity
1
Insider Buys Sum
$9,802.88
Insider Sells Quantity
4
Insider Sells Sum
$1.43M

Insider Activity of Oltmans Curtis Gale

According to the SEC Form 4 filings, Oltmans Curtis Gale, being in a position of

  1. Chief Legal Officer at Fulcrum Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 3452 shares for $44,600,
    over all time since 2021-06-28, has bought 1088 shares for $9,803, and sold 3452 shares for $44,600.

Biography of Oltmans Curtis Gale

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $44,6001100

Comparison of Insiders on Amount of Buys and Sells

2025-12-15SaleFulcrum Therapeutics, Inc.
FULC
Chief Legal Officer
3,452
0.0064%
$12.92$44,600-50.58%
2021-06-28PurchaseFulcrum Therapeutics, Inc.
FULC
SVP, General Counsel
1,088
0.0033%
$9.01$9,803+68.04%
2019-02-05SaleArray Technologies, Inc.
ARRY
General Counsel
40,000
0.0785%
$20.00$800,000
2019-01-25SaleArray Technologies, Inc.
ARRY
General Counsel
14,029
0.0248%
$18.00$252,523
2019-01-18SaleArray Technologies, Inc.
ARRY
General Counsel
1,251
0.0022%
$18.00$22,518
2019-01-15SaleArray Technologies, Inc.
ARRY
General Counsel
19,720
0.0349%
$18.06$356,139
Total: 6
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.